Compugen (CGEN) Non-Current Assets (2009 - 2026)
Compugen recorded quarterly Non-Current Assets of $8.6 million in Q1 2026, little changed quarter-over-quarter from $8.5 million in Q4 2025.
Compugen's Non-Current Assets history runs 11 years deep, the most recent figure standing at $8.6 million for Q1 2026.
- In Q1 2026, Non-Current Assets changed N/A year-over-year to $8.6 million; the TTM figure through Mar 2026 stood at $8.6 million (changed N/A YoY), while the FY2025 annual figure was $8.5 million, down 5.0% from the prior year.
- Non-Current Assets came in at $8.6 million for Q1 2026 at Compugen, roughly flat from $8.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $9.0 million in Q4 2024 to a low of $6.8 million in Q4 2023.
- A 5-year average of $8.2 million and a median of $8.5 million in 2025 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets fell 16.1% in 2023 and surged 33.21% in 2024, its largest moves.
- Compugen's Non-Current Assets stood at $8.1 million in 2022, then dropped by 16.1% to $6.8 million in 2023, then soared by 33.21% to $9.0 million in 2024, then decreased by 5.0% to $8.5 million in 2025, then increased by 0.34% to $8.6 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $8.6 million, $8.5 million, and $9.0 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 8.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.58 Mn |
| Dec 31, 2025 | 8.55 Mn |
| Sep 30, 2025 | 8.93 Mn |
| Jun 30, 2025 | 8.88 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Dec 31, 2024 | 9.00 Mn |
| Sep 30, 2024 | 8.69 Mn |
| Jun 30, 2024 | 8.03 Mn |
| Mar 31, 2024 | 8.13 Mn |
| Dec 31, 2023 | 6.76 Mn |
| Sep 30, 2023 | 7.34 Mn |
| Jun 30, 2023 | 7.66 Mn |
| Mar 31, 2023 | 7.88 Mn |
| Dec 31, 2022 | 8.05 Mn |
| Sep 30, 2022 | 8.33 Mn |
| Jun 30, 2022 | 8.33 Mn |
| Mar 31, 2022 | 8.81 Mn |
| Dec 31, 2021 | 8.94 Mn |
| Sep 30, 2021 | 9.01 Mn |
| Jun 30, 2021 | 9.06 Mn |
| Mar 31, 2021 | 8.89 Mn |
| Dec 31, 2020 | 4.48 Mn |
| Sep 30, 2020 | 9.22 Mn |
| Jun 30, 2020 | 8.77 Mn |
| Mar 31, 2020 | 8.86 Mn |
| Dec 31, 2019 | 8.76 Mn |
| Sep 30, 2019 | 8.98 Mn |
| Jun 30, 2019 | 10.49 Mn |
| Mar 31, 2019 | 11.20 Mn |
| Dec 31, 2018 | 6.60 Mn |
| Sep 30, 2018 | 6.53 Mn |
| Jun 30, 2018 | 6.67 Mn |
| Mar 31, 2018 | 7.09 Mn |
| Dec 31, 2017 | 7.57 Mn |
| Sep 30, 2017 | 7.72 Mn |
| Jun 30, 2017 | 8.08 Mn |
| Mar 31, 2017 | 8.33 Mn |
| Dec 31, 2016 | 8.46 Mn |
| Sep 30, 2016 | 8.57 Mn |
| Jun 30, 2016 | 8.55 Mn |
| Mar 31, 2016 | 8.68 Mn |
| Dec 31, 2015 | 8.31 Mn |
| Sep 30, 2015 | 19.98 Mn |
| Jun 30, 2015 | 5.13 Mn |
| Mar 31, 2015 | 39.93 Mn |
| Dec 31, 2014 | 39.89 Mn |
| Sep 30, 2014 | 4.52 Mn |
| Jun 30, 2014 | 4.37 Mn |
| Mar 31, 2014 | 3.89 Mn |
| Dec 31, 2013 | 3.50 Mn |
| Sep 30, 2013 | 3.54 Mn |
| Jun 30, 2013 | 3.35 Mn |
| Mar 31, 2013 | 3.32 Mn |
| Dec 31, 2012 | 3.34 Mn |
| Sep 30, 2012 | 7.31 Mn |
| Jun 30, 2012 | 7.35 Mn |
| Mar 31, 2012 | 6.75 Mn |
| Dec 31, 2011 | 6.07 Mn |
| Sep 30, 2011 | 6.22 Mn |
| Jun 30, 2011 | 7.10 Mn |
| Mar 31, 2011 | 7.96 Mn |
| Dec 31, 2010 | 8.38 Mn |
| Sep 30, 2010 | 7.38 Mn |
| Jun 30, 2010 | 5.70 Mn |
| Mar 31, 2010 | 7.79 Mn |
| Dec 31, 2009 | 5.88 Mn |
| Sep 30, 2009 | 1.92 Mn |
| Jun 30, 2009 | 1.96 Mn |
| Mar 31, 2009 | 2.25 Mn |